Becton Dickinson stock holds near record levels. Hold rating and results set the tone.
Published on 08/28/2026 at 23:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Becton Dickinson and Company (ISIN US0718131099) traded at $188.11 on August 28, 2026, with MarketBeat data putting its market value at $51.83 billion and its consensus rating at Hold. The same snapshot showed a consensus target price of $185.67, keeping the shares close to the top of their recent range.
Valuation stays stretched
The stock opened at $188.11, and another market snapshot showed a 12-month range of $127.59 to $193.07. That leaves Becton Dickinson within $4.96 of the upper end of the range and 3.9 percent below the 12-month high.
Consensus estimates also point to a cautious setup. The Hold rating and $185.67 target sit below the latest trade, while the P/E ratio of 56.66 and PEG ratio of 13.41 leave little room for earnings disappointment.
Latest results frame the move
The most recent operating context in the results calendar points to second-quarter 2026 revenue of $4.714 billion versus $4.672 billion expected, a 0.9 percent beat. The same calendar shows second-quarter 2026 EPS of $3.34 versus $3.19 expected, a 4.7 percent surprise.
That matters because the company is still trading with elevated multiples even after the earnings beat. In the same calendar, the next reported quarter is listed for August 29, 2026, which keeps attention on guidance and margin detail.
Recent trading context
One market snapshot showed 1,353,617 shares changing hands against an average volume of 2,623,575, while another quoted the stock at $188.07 with a 1.18 percent daily decline. The YTD gain in the same market feed stood at 21.89 percent.
For investors, the key comparison is simple: the shares trade close to a 12-month high even as consensus sits below the last price and the valuation remains rich.
Product line
Becton Dickinson's business spans devices and diagnostic tools used in hospitals, laboratories, and outpatient care. That mix still gives the company exposure to recurring demand in needles, syringes, infusion systems, and infection-prevention products.
Stock view
Becton Dickinson stock last changed hands at $188.11 on August 28, 2026, according to the latest market snapshot. The market cap was $51.83 billion, and the 12-month high stood at $193.07.
Fact box
Company: Becton Dickinson and Company
ISIN: US0718131099
Ticker: BDX
Exchange: NYSE
Price (as of August 28, 2026): $188.11 USD
Market cap: $51.83 billion
Sector / Industry: Health Care / Health Care Equipment
Index membership: S&P 500
Next earnings date: August 29, 2026
